Studies have shown that FOXM1 expression is increased in cisplatin-resistant cancer tissues, and that FOXM1 promotes the malignant behavior of ovarian cancer and induces cisplatin chemoresistance. This evidence concerns the gene FOXM1 and ovarian cancer.